Research keywords (5)：
Vaccine development
, 臨床開発
, 臨床薬理学
, Clinical development
, Clinical pharmacology
Research theme for competitive and other funds (10)：
2023 - 2024 Immune Persistence and Safety Cohort Survey on Booster vaccination of the Newly developed SARS-CoV-2 Vaccine in Japan
2022 - 2023 Immune Persistence and Safety Cohort Survey on Booster vaccination of the SARS-CoV-2 Vaccine in Japan
2021 - 2022 Safety Cohort Survey on vaccination of the SARS-CoV-2 Vaccine in Japan
2020 - 2021 Research on identifying issues related to vaccine supply and considering solutions to them
2020 - 2021 日本語 英語 韓国語 原文 細胞培養インフルエンザワクチンに関する研究 Saibō baiyō infuruenzawakuchin ni kansuru kenkyū 21 / 5,000 翻訳結果 翻訳の結果 Research on cell culture influenza vaccine
2017 - 2018 Central Institutional Review Board/Central Ethics Review Committee Infrastructure Development Project
2016 - 2017 Survey on medical expenses for patients with liver cirrhosis and liver cancer due to hepatitis B and C
2016 - 2017 Exploratory research with a view to building a disease baseline database and utilizing it for vaccination measures using the National Clinical Data Aggregation Platform (NCDA)
Megumu K. Saito, Mitsujiro Osawa, Nao Tsuchida, Kotaro Shiraishi, Akira Niwa, Knut Woltjen, Isao Asaka, Katsuhisa Ogata, Suminobu Ito, Shuzo Kobayashi, et al. A disease-specific iPS cell resource for studying rare and intractable diseases. Inflammation and Regeneration. 2023. 43. 1
Tomonori Iyoda, Kanako Shimizu, Masami Kawamura, Jun Shinga, Takashi Watanabe, Koya Fukunaga, Taisei Mushiroda, Hideo Saka, Chiyoe Kitagawa, Shin-ichiro Shimamatsu, et al. Augmenting Granzyme B-Expressing NK Cells by Invariant NKT Ligand-Loaded APCs in Patients with Postoperative Early Stage Non-Small Cell Lung Cancer: Results of a Randomized Phase II Study. ImmunoHorizons. 2023. 7. 1. 1-16
Toshio Naito, Nao Tsuchida, Susumu Kusunoki, Yoshihiro Kaneko, Morikuni Tobita, Satoshi Hori, Suminobu Ito. Reactogenicity and immunogenicity of BNT162b2 or mRNA-1273 COVID-19 booster vaccinations after two doses of BNT162b2 among healthcare workers in Japan: a prospective observational study. Expert Review of Vaccines. 2022. 21. 9. 1319-1329
Hideyuki Sawada, Tomoko Oeda, Masayuki Kohsaka, Atsushi Umemura, Satoshi Tomita, Kwiyoung Park, Kouichi Mizoguchi, Hidenori Matsuo, Kazuko Hasegawa, Harutoshi Fujimura, et al. Early use of donepezil against psychosis and cognitive decline in Parkinson’s disease: a randomised controlled trial for 2 years. Journal of Neurology, Neurosurgery & Psychiatry. 2018. 89. 12. 1332-1340
Hideo Saka, Chiyoe Kitagawa, Yukito Ichinose, Mitsuhiro Takenoyama, Hidenori Ibata, Tatsuo Kato, Koji Takami, Motohiro Yamashita, Tadashi Maeda, Sadanori Takeo, et al. A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II-IIIA non-small cell lung cancer: study protocol for a randomized controlled trial. Trials. 2017. 18. 1
- 1982 Shinshu University School of Medicine Department of Medicine
Professional career (1)：
Ph.D (Shinshu University)
Work history (6)：
2022/04 - 現在 Juntendo University Medical Technology Innovation Center Professor
2016/04 - 2022/03 National Hospital Organization Headquarters Clinical Reserch Center Director
2005 - 2022/03 Juntendo University Graduate School of Medicine
2010/04 - 2016/03 National Hospital Organization Headquarters Clicical Research Center Director, Dept. of Clinical Research
2005/04 - 2010/04 National Hospital Organization
2002/04 - 2005 Juntendo University Faculty of Medicine
Show all
Committee career (5)：
2016/05 - 現在 厚生労働省厚生科学審議会 予防接種・ワクチン分科会
2009 - 2022/09 厚生労働省 先進医療技術審査部会構成員
2003 - 2013 厚生労働省中央社会保険医療協議会 保健医療専門審査員(DPC評価分科会)
2002 - 2008 厚生労働省 医師試験委員
2003 - 2007 厚生労働省 薬事・食品衛生審議会専門委員
Association Membership(s) (5)：
THE JAPANESE ASSOCIATION FOR INFECTIOUS DISEASES
, JAPANESE SOCIETY OF PSYCHOSOMATIC MEDICINE
, THE JAPANESE SOCIETY OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
, THE JAPANESE SOCIETY OF INTERNAL MEDICINE
, 日本糖尿病学会
